The FDA would receive $4.7 billion for its drug, medical device and biologic surveillance, an $821 million increase over 2012, under a budget proposal released by HHS for 2014. A total of $1.29 billion will go toward the FDA's drug program, $435 million for medtech and $338 million for biologics, which will be supplemented by the user fees paid for new product reviews.
FDA would get $821M boost under HHS budget proposal for 2014
SmartBrief Job Listings for Health Care
|Chief Financial Officer||
B. E. Smith
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|